Crit Care
Critical Care
1364-8535
1466-609X
BioMed Central
London


468887
cc2418
15153235
10.1186/cc2418
Review


Clinical review: Influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock

Asfar
Pierre

1

De Backer
Daniel

2

Meier-Hellmann
Andreas

3

Radermacher
Peter

4
peter.radermacher@medizin.uni-ulm.de

Sakka
Samir G

5


1
Staff Physician, Département de Réanimation Médicale, Centre Hospitalier Universitaire, Angers, France
2
Staff Physician, Département de Réanimation Médicale, Hôpital Erasme, Université Libre, Bruxelles, Belgium
3
Head, Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, Helios Klinikum, Erfurt, Germany
4
Section Head, Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum, Ulm, Germany
5
Staff Physician, Department of Anesthesiology and Intensive Care Medicine, Friedrich-Schiller University, Jena, Germany
2004

29
12
2003

8
3
170
179
Copyright © 2004 BioMed Central Ltd 
N
-acetyl cysteine.

adrenergic drugs
nonconventional treatments
septic shock
splanchnic circulation
supportive treatment



Introduction
1
2
]. In fact, because of its peculiar vascular anatomy, the hepatosplanchnic area is jeopardized during septic shock, which may potentially lead to a vicious circle of inflammatory responses, culminating in multiple organ failure syndrome.
The present clinical review briefly discusses the splanchnic vascular anatomy and focuses on the different therapeutic approaches that have been proposed to promote perfusion of the gastrointestinal tract during resuscitation of patients with septic shock. When possible and reasonable, we propose therapeutic recommendations.
N
-acetyl cysteine, dialysis and haemofiltration. We also reviewed the reference lists of all available review articles and primary studies to identify references not found in computerized searches. We placed emphasis on prospective, randomized, controlled clinical trials.

Anatomy of hepatosplanchnic vascular bed
1
3
4
4
5
].
6
7
].
8
9
10
12
13
].
CO
2
CO
2 
CO
2
CO
2 
14
CO
2 
CO
2 
15
CO
2 
10
16
CO
2 
gap must be interpreted with caution.

Therapeutic strategies
Fluid challenge
17
18
].
19
20
22
CO
2 
CO
2 
20
23
].
24
25
26
].

Adrenergic drugs
The choice of vasoactive drugs in sepsis and septic shock is controversial. There is no evidence that any one vasoactive drug is more effective or safer than any other. Larger trials are needed to elucidate existing clinically significant differences in morbidity and mortality. A multicentre trial, which is currently ongoing, is comparing the effects of epinephrine with a combination of a fixed dose of dobutamine in addition to norepinephrine.
1
)
27
27
30
CO
2 
30
28
31
2
, which was associated with a significant reduction in splanchnic oxygen consumption.
32
33
34
] reported that dopamine administered at doses up to 25 μg/kg per min even decreased pHi. Given the very small number of patients included in these studies, no definite conclusions can be drawn regarding the effects of dopamine on splanchnic blood flow in septic patients.
32
34
35
CO
2 
CO
2 
gap remained unaltered by any of the treatments.
1
), no definite conclusions can be drawn regarding differences between dopamine and norepinephrine on splanchnic blood flow and metabolism in patients with septic shock.

2
3
)
24
24
36
37
39
39
40
41
CO
2 
CO
2 
gap was not affected in patients when this gradient was less than 20%. This suggests that patients with the most severe alterations in hepatosplanchnic blood flow are also prone to decreased mucosal perfusion.
40
42
39
43
] reported that splanchnic oxygen consumption increased during dobutamine administration only in patients with an increased gradient between hepatic venous and mixed venous oxygen saturation.
44
].
45
11
46
CO
2 
38
].
42
41
43
CO
2 
gap.
2
3
, respectively.

Recommendations regarding use of adrenergic drugs
45
]. Epinephrine should be reserved for use as rescue therapy. If norepinephrine is chosen as the first agent, then the addition of dobutamine may be considered.


Dopexamine
30
47
7
] employed reflectance spectrophotometry for direct assessment of the microvascular haemoglobin saturation and haemoglobin concentration in the gastric mucosa in patients with septic shock. Compared with healthy control individuals, patients with septic shock exhibited a reduced microvascular haemoglobin saturation with a wide distribution and with tailing of the histogram to severely hypoxic values in spite of high whole body oxygen delivery. This microvascular disturbance was associated with reduced microvascular haemoglobin concentration and a lower gastric pHi. Short-term infusion of 2 μg/kg per min dopexamine in 10 patients with septic shock increased both microvascular haemoglobin saturation and concentration, whereas whole body oxygen uptake and gastric pHi remained unaltered.
48
49
50
CO
2 
51
]. Given these discrepancies, it is reasonable to recommend further investigations into dopexamine before it may be routinely used in septic shock.

Other vasoactive drugs
Vasopressin and terlipressin
52
].
53
54
]. However, the effects of vasopressin on regional (i.e. splanchnic) blood flow are discussed controversially.
52
55
CO
2 
gradient did not change significantly in either group.
56
CO
2 
56
CO
2 
57
60
61
CO
2 
gap was significantly lower in patients treated with this combination. However, these patients also presented with a significant increase in plasma bilirubin concentration, suggesting an impaired liver blood flow and/or a depressed hepatic function mediated by vasopressin.
62
63
64
CO
2 
gap progressively increased over 72 hours.
Both vasopressin and terlipressin are potent vasoconstrictors and both are able to restore blood pressure in vasodilatory or septic shock. However, the effects on splanchnic blood flow are not yet fully elucidated. Clearly, adequacy of volume resuscitation is a major prerequisite for maintenance of microcirculatory blood flow. The currently available data suggest that both substances administered to compensate for endogenous vasopressin deficiency may be beneficial. Although the armamentarium for treatment of septic shock is enriched by such substances, it remains unclear whether administration during septic shock decreases morbidity or improves survival, and further research is warranted.

Enoximone
65
]. Phosphodiesterase III inhibitors have positive inotropic, vasodilating and anti-inflamatory properties, and they may avoid the development of tolerance to catecholamines as a result of β-receptor desensitization.
66
P 
< 0.05) as during enoximone treatment, suggesting a faster anti-inflammatory effect of enoximone. These interesting findings on hepatosplanchnic effects of phosphodiesterase III inhibitors were not confirmed by other studies, and further investigations are needed if these agents are to be recommended for routine clinical use.

Prostacyclin
67
68
69
70
] reported restored plasma ICG clearance without harmful effect on systemic haemodynamics in patients with septic shock treated with iloprost.
71
CO
2 
72
].

Nitroglycerin
73
] suggest that the use of intravenous nitroglycerin results in improved sublingual microvascular flow, as assessed by orthogonal polarization spectral imaging. However, one cannot assume that the sublingual microcirculation necessarily behaves like the whole splanchnic microcirculation does.

N-acetyl cysteine
N
74
75
76
CO
2 
75
77
78
]. Is NAC a 'double edged sword'? This question should be answered before its use in daily practice can be recommended.


Extracorporeal renal support
CO
2 
79
80
81
CO
2 
80
82
81
].


Conclusion
CO
2 
gap, but none of these studies reported convincing results with respect to mortality and/or morbidity.

Competing interests
None declared.

Abbreviations
N
CO
2 
= partial carbon dioxide tension; pHi = intramucosal pH.


Carrico
CJ

Meakins
JL

Marshall
JC

Fry
D

Maier
RV


Multiple organ failure syndrome. The gastrointestinal tract: the 'motor' of MOF
Arch Surg
1986
121
196
208
3484944


Dantzker
DR


The gastrointestinal tract. The canary of the body?
JAMA
1993
270
1247
1248
8355390
10.1001/jama.270.10.1247


Lautt
WW


Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response
Am J Physiol
1985
249
G549
G556
3904482


Dahn
MS

Lange
P

Lobdell
K

Hans
B

Jacobs
LA

Mitchell
RA


Splanchnic and total body oxygen consumption differences in septic and injuried patients
Surgery
1987
101
69
80
3798330


Uusaro
A

Ruokonen
E

Takala
J


Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green
Cardiovasc Res
1995
30
106
112
7553712
10.1016/0008-6363(95)00007-0


Reilly
PM

Wilkins
KB

Fuh
KC

Haglund
U

Bulkley
GB


The mesenteric hemodynamic response to circulatory shock: an overview
Shock
2001
15
329
343
11336191


Temmesfeld-Wollbrück
B

Szalay
A

Mayer
K

Olschewski
H

Seeger
W

Grimminger
F


Abnormalities of gastric mucosal oxygenation in septic shock
Am J Respir Crit Care Med
1998
157
1586
1592
9603142


Meier-Hellmann
A

Specht
M

Hannemann
L

Hassel
H

Bredle
DL

Reinhart
K


Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis
Intensive Care Med
1996
22
1354
1359
8986486
10.1007/s001340050264


De Backer
D

Creteur
J

Silva
E

Vincent
JL


The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis
Crit Care Med
2001
29
256
261
11246302
10.1097/00003246-200102000-00005


Tugtekin
IF

Radermacher
P

Theisen
M

Matejovic
M

Stehr
A

Ploner
F

Matura
K

Ince
C

Georgieff
M

Träger
K


2 
gap is associated with impaired villus microcirculation in endotoxic pigs
Intensive Care Med
2001
15
757
766
10.1007/s001340100871


Duranteau
J

Sitbon
P

Teboul
JL

Vicaut
E

Anguel
N

Richard
C

Samii
K


Effects of epinephrine, norepinephrine or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock
Crit Care Med
1999
27
893
900
10362410
10.1097/00003246-199905000-00021


De Backer
D

Creteur
J

Preiser
JC

Dubois
MJ

Vincent
JL


Microvascular blood flow is altered in patients with sepsis
Am J Respir Crit Care Med
2002
166
98
104
12091178
10.1164/rccm.200109-016OC


Fink
MP


Bench-to-bedside review: Cytopathic hypoxia
Crit Care
2003
6
491
499
10.1186/cc1824


Levy
B

Gawalkiewicz
P

Vallet
B

Briancon
S

Nace
L

Bollaert
PE


Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients
Crit Care Med
2003
31
474
480
12576954
10.1097/01.CCM.0000050445.48656.28


Creteur
J

De Backer
D

Vincent
JL


Does gastric tonometry monitor splanchnic perfusion?
Crit Care Med
1999
27
2480
2484
10579268
10.1097/00003246-199911000-00026


Uusaro
A

Russell
JA

Walley
KR

Takala
J


2 
gradient does not reflect systemic and splanchnic hemodynamics or oxygen transport after cardiac surgery
Shock
2000
14
13
17
10909887


Hollenberg
SM

Ahrens
TS

Astiz
ME

Chalfin
DB

Dasta
JF

Heard
SO

Martin
C

Susla
GM

Vincent
JL


Practice parameters for hemodynamic support of sepsis in adult patients in sepsis
Crit Care Med
1999
27
639
660
10199548


Choi
PT

Yip
G

Quinonez
LG

Cook
DJ


Crystalloids vs. colloids in fluid resuscitation: a systematic review
Crit Care Med
1999
27
200
210
9934917
10.1097/00003246-199901000-00053


Boldt
J

Heesen
M

Müller
M


The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients
Anesth Analg
1996
83
254
261
8694302


Asfar
P

Kerkeni
N

Labadie
F

Gouello
JP

Brenet
O

Alquier
P


Assessment of hemodynamic and gastric mucosal acidosis with modified fluid gelatin versus 6% hydroxyethyl starch: a prospective randomized study
Intensive Care Med
2000
26
1282
1287
11089754
10.1007/s001340000606


Sakka
SG

Meier-Hellmann
A

Reinhart
K


Do fluid administration and reduction in norepinephrine dose improve global and splanchnic haemodynamics?
Br J Anaesth
2000
84
758
762
10895752


Forrest
DM

Baigorri
F

Chittock
DR

Spinelli
JJ

Russel
JA


2 
gradient or gastric intramucosal pH in patients who have sepsis syndrome
Crit Care Med
2000
28
2254
2258
10921549


Shortgen
F

Brochard
L

Burnham
E

Martin
GS


Pro/Con clinical debate: Hydroxyethylstarches should be avoided in septic patients
Crit Care
2003
7
279
281
12930549
10.1186/cc1885


Silverman
H

Tuma
P


Gastric tonometry in patients with sepsis: effects of dobutamine infusions and packed red blood cell transfusions
Chest
1992
102
184
188
1623750


Marik
PE

Sibbald
WJ


Effect of stored-blood transfusion on oxygen delivery in patients with sepsis
JAMA
1993
16
3024
3029


Fernandes
CJ

Akamine
N

De Marco
FVC

De Souza
JAM

Lagudis
S

Knobel
E


Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients
Crit Care
2001
5
362
367
11737926
10.1186/cc1070


Nevière
R

Mathieu
D

Chagnon
JL

Lebleu
N

Wattel
F


The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients
Am J Respir Crit Care Med
1996
154
1684
1688
8970355


Meier-Hellmann
A

Bredle
DL

Specht
M

Hannemann
L

Reinhart
K


The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock
Intensive Care Med
1997
23
31
37
9037637
10.1007/s001340050287


Olson
D

Pohlman
A

Hall
JB


Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH not improve creatinine clearance
Am J Respir Crit Care Med
1996
154
1664
1670
8970352


Maynard
ND

Bihari
DJ

Dalton
RN

Smithies
MN

Mason
RC


Increasing splanchnic blood flow in the critically ill
Chest
1995
108
1648
1654
7497776


Jakob
SM

Ruokonen
E

Takala
J


Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients
Shock
2002
18
8
13
12095139
10.1097/00024382-200207000-00002


Ruokonen
E

Takala
J

Kari
A

Saxén
H

Mertsola
J

Hansen
EJ


Regional blood flow and oxygen transport in septic shock
Crit Care Med
1993
21
1296
1303
8370292


Ruokonen
E

Takala
J

Uusaro
A


Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation
Crit Care Med
1991
19
1365
1369
1935155


Marik
PE

Mohedin
M


The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis
JAMA
1994
272
1354
1357
7933396
10.1001/jama.272.17.1354


De Backer
D

Creteur
J

Silva
E

Vincent
JL


Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is the best?
Crit Care Med
2003
31
1659
1667
12794401
10.1097/01.CCM.0000063045.77339.B6


Gutierrez
G

Clark
C

Brown
SD

Price
K

Ortiz
L

Nelson
C


Effects of dobutamine on oxygen consumption and gastric mucosal pH in septic patients
Am J Respir Crit Care Med
1994
150
324
329
8049810


Zhou
SX

Qiu
HB

Huang
YZ

Yang
Y

Zheng
RQ


Effects of norepinephrine, epinephrine, norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock
Acta Pharmacol Sin
2002
23
654
658
12100762


Levy
B

Nace
L

Bollaert
PE

Dousset
B

Mallie
JP

Larcan
A


Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock
Intensive Care Med
1997
23
282
287
9083230
10.1007/s001340050329


Joly
LM

Monchi
M

Carriou
A

Chiche
JD

Bellenfant
F

Brunet
F

Dhainaut
JF


Effect of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock
Am J Respir Crit Care Med
1999
160
1983
1986
10588617


Ruokonen
E

Uusaro
A

Alhava
E

Takala
J


The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis
Intensive Care Med
1997
23
732
737
9290985
10.1007/s001340050401


Creteur
J

De Backer
D

Vincent
JL


A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients
Am J Respir Crit Care Med
1999
160
839
845
10471606


Reinelt
H

Radermacher
P

Fischer
G

Geisser
W

Wachter
U

Wiedeck
H

Georgieff
M

Vogt
J


Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock
Anesthesiology
1997
86
818
824
9105226
10.1097/00000542-199704000-00012


De Backer
D

Creteur
J

Noordally
O

Smail
N

Gulbis
B

Vincent
JL


Does hepatosplanchnic VO2/DO2 dependency exist in critically ill patients?
Am J Respir Crit Care Med
1998
157
1219
1225
9563742


Reinelt
H

Radermacher
P

Kiefer
P

Fischer
G

Wachter
U

Vogt
J

Georgieff
M


Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock
Crit Care Med
1999
27
325
331
10075057
10.1097/00003246-199902000-00039


Meier-Hellmann
A

Reinhart
K

Bredle
DL

Specht
M

Spies
CD

Hannemann
L


Epinephrine impairs splanchnic perfusion in septic shock
Crit Care Med
1997
25
399
404
9118653
10.1097/00003246-199703000-00005


Seguin
P

Bellissant
E

Le Tulzo
Y

Laviolle
B

Lessard
Y

Thomas
R

Malledant
Y


Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock
Clin Pharmacol Ther
2002
71
381
388
12011824
10.1067/mcp.2002.122471


Smithies
M

Tee
TH

Jackson
L

Beale
R

Bihari
D


Protecting the gut and the liver in the critically ill: effects of dopexamine
Crit Care Med
1994
22
789
795
8181287


Hannemann
L

Reinhart
K

Meier-Hellmann
A

Wallenfang
G

Bredle
DL


Dopexamine hydrochloride in septic shock
Chest
1996
109
756
760
8617087


Meier-Hellmann
A

Bredle
DL

Specht
M

Hannemann
L

Reinhart
K


Dopexamine increases splanchnic blood flow but decreases gastric mucosal pHi in severe septic patients treated with dobutamine
Crit Care Med
1999
27
2166
2171
10548200
10.1097/00003246-199910000-00015


Kiefer
P

Tugtekin
E

Wiedeck
H

Bracht
H

Geldner
G

Georgieff
M

Radermacher
P


Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock
Am J Respir Crit Care Med
2000
161
775
779
10712321


Kiefer
P

Tugtekin
I

Wiedeck
H

Vogt
J

Wachter
U

Bracht
H

Geldner
G

Georgieff
M

Radermacher
P


Effect of dopexamine on hepatic metabolic activity in patients with septic shock
Shock
2001
15
427
431
11386613


Landry
DW

Levin
HR

Gallant
HM

Ashton
RC

Seo
S

D'Alessandro
D

Oz
M

Oliver
JA


Vasopressin deficiency contributes to the vasodilation of septic shock
Circulation
1997
95
1122
1125
9054839


Oliver
JA

Landry
DW


Patient with a sudden drop in blood pressure
Crit Care Med
2003
31
326
327
12545047
10.1097/00003246-200301000-00062


American Heart Association and International Liaison on Cardiopulmonary Resuscitation

Advanced cardiovascular life support. Pharmacology II: agents to optimize cardiac output and blood pressure
Resuscitation
2000
46
155
162
10978796
10.1016/S0300-9572(00)00279-3


Patel
BM

Chittock
DR

Russell
JA

Walley
KR


Beneficial effects of short-term vasopressin infusion during severe septic shock
Anesthesiology
2002
96
576
582
11873030


Klinzing
S

Simon
M

Reinhart
K

Bredle
DL

Meier-Hellmann
A


High-dose vasopressin is not superior to norepinephrine in septic shock
Crit Care Med
2003
31
2646
2650
14605537


Tsuneyoshi
I

Yamada
H

Kakihana
Y

Nakamura
M

Nakano
Y

Boyle
WA


Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock
Crit Care Med
2001
29
487
493
11373409
10.1097/00003246-200103000-00004


Landry
DW

Levin
HR

Gallant
EM

Seo
S

D'Alessandro
D

Oz
MC

Oliver
JA


Vasopressin pressor hypersensitivity in vasodilatory septic shock
Crit Care Med
1997
25
1279
1282
9267938
10.1097/00003246-199708000-00012


Holmes
CL

Walley
KR

Chittock
DR

Lehman
T

Russell
JA


The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series
Intensive Care Med
2001
27
1416
1421
11511958
10.1007/s001340101014


Ryan
DW

Kilner
AJ


What about vasopressin?
Intensive Care Med
2002
28
810
811
12269244
10.1007/s00134-002-1301-y


Dünser
MW

Mayr
AJ

Ulmer
H

Knotzer
H

Sumann
G

Pajk
W

Friesenecker
B

Hasibeder
WR


Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study
Circulation
2003
107
2313
2319
12732600
10.1161/01.CIR.0000066692.71008.BB


O'Brien
A

Clapp
L

Singer
M


Terlipressin for norepinephrine-resistant septic shock
Lancet
2002
359
1209
1210
11955542
10.1016/S0140-6736(02)08225-9


Westphal
M

Bone
H-G

Van Aken
H

Sielenkämper
AW


Terlipressin for haemodynamic support in septic patients: a double-edged sword?
Lancet
2002
360
1250
1251
12401276
10.1016/S0140-6736(02)11253-0


Auzinger
GM

O'Callaghan
PG

Harry
RA

Wendon
JA


Terlipressin in the treatment of catecholamine resistant septic shock [abstract]
Crit Care
2002
Suppl 1
61


Uusaro
A

Russell
JA


Could anti-inflamatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients
Intensive Care Med
2000
26
299
304
10823386
10.1007/s001340051153


Kern
H

Schröder
T

Kaulfuss
M

Martin
M

Kox
WJ

Spies
CD


Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients
Crit Care Med
2001
29
1519
1525
11505119
10.1097/00003246-200108000-00004


Bihari
D

Smithies
M

Gimson
A

Tinker
J


The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients
N Engl J Med
1987
317
397
403
3302704


Radermacher
P

Buhl
P

Santak
B

Klein
M

Kniemeyer
HW

Becker
H

Tarnow
J


The effects of prostacyclin on gastric intramucosal pH in patients with septic shock
Intensive Care Med
1995
21
414
421
7665751


Eichelbrönner
O

Reinelt
H

Wiedeck
H

Mezödy
M

Rossaint
R

Georgieff
M

Radermacher
P


Aerosolized prostacyclin and inhaled nitric oxide in septic shock-different effects on splanchnic oxygenation?
Intensive Care Med
1996
22
880
887
8905421
10.1007/s001340050182


Lehmann
C

Taymoorian
K

Wauer
H

Krausch
D

Birnbaum
J

Kox
WJ


Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock
Intensive Care Med
2000
26
1557
1560
11126272
10.1007/s001340000662


Kiefer
P

Tugtekin
I

Wiedeck
H

Bracht
H

Vogt
J

Wachter
U

Weiss
M

Altin
C

Georgieff
M

Radermacher
P


Hepatosplanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock
Intensive Care Med
2001
27
1179
1186
11534566
10.1007/s001340100954


Buwalda
M

Ince
C


Opening the microcirculation: can vasodilators be useful in sepsis?
Intensive Care Med
2002
28
1208
1217
12209267
10.1007/s00134-002-1407-2


Spronk
PE

Ince
C

Gardien
MJ

Mathura
KR

Oudemans-van Straaten
HM

Zandstra
DF


Nitroglycerin in septic shock after intravascular volume resuscitation
Lancet
2002
360
1395
1396
12423989
10.1016/S0140-6736(02)11393-6


Spies
CD

Reinhart
K

Witt
I

Meier-Hellmann
A

Hannemann
L

Bredle
DL

Scharffartzik
W


Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results of a prospective, randomized, double blind study
Crit Care Med
1994
22
1738
1746
7956276


Rank
N

Michel
C

Haertel
C

Lenhart
A

Welte
M

Meier-Hellmann
A

Spies
C


N-acetylcycteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double blind study
Crit Care Med
2000
28
3799
3807
11153617


Reinhart
K

Spies
CD

Meier-Hellmann
A

Bredle
DL

Hannemann
L

Specht
M

Schaffartzik
W


N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation
Am J Respir Crit Care Med
1995
151
773
779
7881669


Peake
SL

Moran
JL

Leppard
PI


N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock
Crit Care Med
1996
24
1302
1310
8706483
10.1097/00003246-199608000-00006


Molnár
Z

Shearer
E

Lowe
D


N-acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study
Crit Care Med
1999
27
1100
1104
10397212
10.1097/00003246-199906000-00028


Van der Schueren
G

Diltoer
M

Laureys
M

Huyghens
L


Intermittent dialysis in critically ill patients with multiple organ dysfunction syndrome is assossiated with intestinal intramucosal acidosis
Intensive Care Med
1996
22
747
751
8880242
10.1007/s001340050162


Jakob
SM

Ruokonen
E

Vuolteenaho
O

Lampainen
E

Takala
J


Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion
Crit Care Med
2001
29
1393
1398
11445693
10.1097/00003246-200107000-00015


John
S

Griesbach
D

Baumgärtel
M

Weihprecht
H

Schmieder
RE

Geiger
H


vs 
intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial
Nephrol Dial Transplant
2001
16
320
327
11158407
10.1093/ndt/16.2.320


Davenport
A

Will
EJ

Davison
AM


Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure
Crit Care Med
1993
21
328
338
8440100



Figures and Tables
Figure 1
Splanchnic anatomy and flows in healthy volunteers.



Table 1
Clinical studies reporting effects of dopamine on splanchnic haemodynamics

Reference
n

Drug (μg/kg per min)
Splanchnic blood flow
CO
2 
gap
Comments


27
]
10
Dopamine 5
LD ↓
CO
2 
gap =
Laser Doppler study; cross-over trial



Dobutamine 5
LD ↑
CO
2 
gap ↓


29
]
16
Dopamine 3
NA
pHi =


28
]
11
Dopamine 3 + norepinephrine
HSBF ↑
pHi =
Increase in fractional splanchnic flow when low before dopamine

30
]
10
Dopamine 2.5
=
pHi =
Splanchnic blood flow was measured by ICG clearance


10
versus dopexamine 1
↑
pHi ↑


31
]
9
Dopamine 4 (2.1–9)
HSBF ↑
NA
O
2
; dopamine infused to achieve increase of 25% in cardiac index

32
]
5
Dopamine 16
HSBF ↑




5
versus norepinephrine 0.13
≈



34
]
10
Dopamine 26
NA
pHi ↓
Dopamine and norepinephrine titrated to achieve MAP ≥ 75 mmHg


10
versus norepinephrine 0.18

pHi ↑


35
]
10
Dopamine 26


Switch from dopamine to norepinephrine or epinephrine in moderate septic shock



versus norepinephrine 0.18
HSBF =
CO
2 
gap =




versus epinephrine 0.12
HSBF =
CO
2 
gap =




CO
2 
CO
2
O
2
, oxygen consumption.


Table 2
Clinical studies reporting effects of dobutamine on splanchnic haemodynamics

Reference
n

Drug (μg/kg per min)
Splanchnic blood flow
CO
2 
gap
Comments


24
]
9
Dobutamine 5
NA
pHi ↑
Dobutamine versus transfusions

36
]
21
Dobutamine 5–10
NA
pHi ↑
Septic patients with low pHi

38
]
15
Dobutamine 5 + norepinephrine 0.6
NA
CO
2 
gap =
Norepinephrine and epinephrine titrated to obtain MAP ≥ 80 mmHg with stable or increased cardiac index


15
versus epinephrine 0.5
NA
CO
2 
gap ↑


39
]
14
Dobutamine 7.5 + norepinephrine 0.6 mg/hour
ICG clearance =
pHi ↓
Patients were treated with norepinephrine and dobutamine was added

40
]
10
Dobutamine 7.3 ± 2
HSBF ≈
NA
Patients with pancreatitis infused with dobutamine to increase cardiac index by > 25%

41
]
36
Dobutamine 5–10
HSBF ↑
CO
2 
gap ↓ in patients with fractional splanchnic blood flow < 20%


42
]
12
Dobutamine NA + norepinephrine 0.2 ± 0.08
HSBF ↑
CO
2 
gap =
Septic patients haemodynamically controlled with norepinephrine (MAP > 70 mmHg); dobutamine infused to achieve increase in cardiac index of > 20%

43
]
42
Dobutamine 5–10
HSBF ↑
NA
O
2 
increased only in patients with increased gradient between hepatic venous and mixed–venous oxygen saturation > 10%



CO
2 
CO
2
O
2
, oxygen consumption.


Table 3
Clinical studies reporting effects of norepinephrine on splanchnic haemodynamics

Reference
n

Drug (μg/kg per min)
Splanchnic blood flow
CO
2 
gap
Comments


44
]
5
Norepinephrine NA versus phenylephrine 3.2
HSBF ↓
CO
2 
gap =
Switch from norepinephrine to phenylephrine

11
]
12
Epinephrine 0.7 ± 0.1 versus norepinephrine 1 ± 0.6 versus norepinephrine + dobutamine 1.1 ± 0.6 and 5
LD ↑ in mucosal blood flow with epinephrine and norepinephrine + dobutamine, as compared with norepinephrine alone
NA
Epinephrine, norepinephrine in random order to achieve MAP 70–80 mmHg

46
]
11
Epinephrine 0.3 ± 0.2
LD epinephrine ↑ mucosal
NA



11
versus norepinephrine + dobutamine 0.9 ± 0.4 and 5
blood flow



45
]
8
Epinephrine 0.48 ± 0.33 versus norepinephrine + dobutamine 0.37 ± 0.2 and 13.6 ± 3
HSBF ↓ with epinephrine
pHi ↓
Cross-over study



CO
2 
CO
2
; pHi, intramucosal pH.





